NCT06177678
A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2024
Completion: Sep 30, 2024